- Home
- NVRI vs RAPP Comparison
NVRI vs RAPP Comparison
Compare NVRI & RAPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVRI
- RAPP
- Stock Information
- Founded
- NVRI 1853
- RAPP 2022
- Country
- NVRI United States
- RAPP United States
- Employees
- NVRI N/A
- RAPP N/A
- Industry
- NVRI Diversified Commercial Services
- RAPP
- Sector
- NVRI Miscellaneous
- RAPP
- Exchange
- NVRI Nasdaq
- RAPP Nasdaq
- Market Cap
- NVRI 996.0M
- RAPP 1.2B
- IPO Year
- NVRI N/A
- RAPP 2024
- Fundamental
- Price
- NVRI $12.21
- RAPP $28.93
- Analyst Decision
- NVRI Hold
- RAPP Strong Buy
- Analyst Count
- NVRI 1
- RAPP 3
- Target Price
- NVRI $10.00
- RAPP $35.33
- AVG Volume (30 Days)
- NVRI 728.1K
- RAPP 387.1K
- Earning Date
- NVRI 11-10-2025
- RAPP 11-07-2025
- Dividend Yield
- NVRI N/A
- RAPP N/A
- EPS Growth
- NVRI N/A
- RAPP N/A
- EPS
- NVRI N/A
- RAPP N/A
- Revenue
- NVRI $2,242,873,000.00
- RAPP N/A
- Revenue This Year
- NVRI N/A
- RAPP N/A
- Revenue Next Year
- NVRI $3.72
- RAPP N/A
- P/E Ratio
- NVRI N/A
- RAPP N/A
- Revenue Growth
- NVRI N/A
- RAPP N/A
- 52 Week Low
- NVRI $4.72
- RAPP $6.43
- 52 Week High
- NVRI $13.53
- RAPP $42.27
- Technical
- Relative Strength Index (RSI)
- NVRI 47.98
- RAPP 59.87
- Support Level
- NVRI $12.54
- RAPP $25.95
- Resistance Level
- NVRI $13.53
- RAPP $29.10
- Average True Range (ATR)
- NVRI 0.49
- RAPP 1.76
- MACD
- NVRI -0.09
- RAPP 0.05
- Stochastic Oscillator
- NVRI 30.16
- RAPP 94.83
About NVRI Enviri Corporation
Enviri Corp is a market-leading, provider of environmental solutions for industrial and specialty waste streams, and equipment and technology for the rail sector. The company's current operations consist of three divisions: Harsco Environmental, Harsco Rail, and Clean Earth. The company gains its revenue from Harsco Environmental segment. Geographically company operates in USA and International Countries, with majority revenue from USA.
About RAPP Rapport Therapeutics Inc. Common Stock
Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.